The Plight of Proprietary: Third-Party Testing for Pet Supply Efficacy

Every pet product on the shelf promises something: longer walks, shinier coats, cleaner teeth, less anxiety. But who actually checks that these promises hold up? The answer, more often than not, is the company selling the product. Proprietary testing—research conducted or commissioned by the brand itself—has become the default standard in the pet supply industry. And that is a problem.

This guide is for experienced pet owners, retailers, and product formulators who have noticed the gap between marketing claims and real-world results. We are not here to bash every brand that runs its own studies. Instead, we want to show you how to read between the lines of efficacy claims, spot the difference between genuine third-party validation and dressed-up internal data, and make smarter decisions for the animals in your care.

The core tension is simple: a company that profits from selling a product also has a strong incentive to design a test that makes that product look good. That does not mean all proprietary testing is worthless—but it does mean you need a framework for evaluating what you see. Let us start with why this matters right now.

Why This Topic Matters Now

The pet supply market has exploded in recent years, with new supplements, functional treats, and high-tech gear arriving weekly. Many of these products lean heavily on scientific-sounding language: “clinically proven,” “vet-recommended,” “tested for efficacy.” The problem is that these phrases are largely unregulated. A brand can run a small internal study with a handful of animals, cherry-pick the positive results, and call it proof.

We have seen this pattern repeat across categories. In joint supplements, for example, a company might test its product on six dogs for two weeks, measure a subjective owner-reported improvement, and publish a glossy report claiming 90% efficacy. A third-party trial with a larger sample, placebo control, and blinded assessment might show no significant difference. The proprietary test was not necessarily fraudulent—it was just designed to find a positive result. That is the plight of proprietary testing: it can be technically honest yet deeply misleading.

The Rise of “Vet-Approved” as a Marketing Shield

Another trend is the use of veterinary endorsements that blur the line between independent opinion and paid promotion. Some brands pay veterinarians to serve on advisory boards or to lend their names to product lines. While these vets may genuinely believe in the product, their involvement does not constitute third-party testing. We have seen cases where a product labeled “vet-approved” had no published peer-reviewed data at all—just a few testimonials from paid consultants.

Regulatory Gaps and Consumer Confusion

Unlike pharmaceuticals, pet supplements and many accessories are not required to prove efficacy before going to market. The FDA’s Center for Veterinary Medicine regulates pet food and certain drugs, but most supplements, topical treatments, and devices fall into a gray area. Manufacturers are responsible for ensuring their products are safe, but they do not need to submit efficacy data to any agency. This leaves the burden of verification on the buyer—and that is where third-party testing becomes crucial.

For the experienced reader, the takeaway is not to dismiss all proprietary research, but to develop a skeptical eye. The rest of this guide will give you the tools to do exactly that.

Core Idea in Plain Language

Third-party testing means that a product’s efficacy is evaluated by an independent organization that has no financial stake in the outcome. This could be a university lab, a contract research organization (CRO), or a nonprofit testing consortium. The key is independence: the tester does not benefit from a positive result, and the study design is not controlled by the brand.

What Makes a Test Truly Third-Party?

Several factors distinguish genuine third-party testing from proprietary studies dressed up as independent. First, the study protocol should be pre-registered—meaning the brand and tester agree on the methods, endpoints, and statistical analysis before any data is collected. This prevents the common practice of “p-hacking,” where researchers run multiple analyses until they find a significant result. Second, the data should be accessible for audit, at least to qualified reviewers. Third, the tester should have the right to publish results regardless of outcome. If a contract allows the brand to suppress unfavorable findings, the independence is compromised.

In practice, we see a spectrum. At one end are products with multiple peer-reviewed studies conducted at independent labs with full disclosure of funding. At the other end are products with a single internal study summarized on a website with no details about sample size, duration, or statistical methods. Most products fall somewhere in between, and our job is to place them on that spectrum accurately.

Why Brands Resist Third-Party Testing

Honest third-party testing is expensive and risky. A well-designed trial with a placebo group, adequate sample size, and objective outcome measures can cost tens of thousands of dollars. And there is always a chance the result will be negative or null. For a brand that has already invested in product development and marketing, a failed trial can be a major setback. Proprietary testing, by contrast, can be done on a shoestring budget and tailored to produce a favorable story. The incentive to avoid independent scrutiny is strong.

That said, some brands do invest in third-party testing and use it as a differentiator. For the discerning buyer, these products are often worth a closer look—not because the test guarantees the product works for your pet, but because the brand has demonstrated a willingness to be held accountable.

How It Works Under the Hood

To evaluate third-party testing claims, you need to understand the basic anatomy of an efficacy study. You do not need a PhD in statistics, but you do need to know what to look for in a report.

Study Design: The Gold Standard and Its Compromises

The strongest design for most pet supply claims is a randomized, double-blind, placebo-controlled trial. In such a study, animals are randomly assigned to receive either the test product or a placebo (or a positive control). Neither the owners nor the researchers assessing outcomes know which group each animal is in. This design eliminates placebo effects—both the owner’s expectation and the animal’s potential response to attention—and biases in outcome assessment.

However, many pet product studies cannot fully blind because the product has a distinctive smell, taste, or appearance. For example, a dental chew that changes breath odor is hard to mask. In those cases, a well-designed study might use an active comparator (another product with known effects) or objective measurements like plaque scoring by a blinded veterinarian. The key is that the study acknowledges the limitation and takes steps to mitigate it.

Sample Size and Statistical Power

A study with too few animals can miss real effects or find false positives due to random variation. For most pet supplement studies, a reasonable sample size is at least 20–30 animals per group, though this depends on the expected effect size. If a study claims efficacy with only 6 or 8 animals total, treat the results as preliminary at best. Many industry surveys suggest that underpowered studies are common in the pet supply sector, often because brands want quick, cheap results.

Outcome Measures: Objective vs. Subjective

Objective measures—like blood tests, weight, joint range of motion, or coat thickness measured by a standardized tool—are more reliable than subjective owner reports. Owner-reported outcomes are valuable but prone to wishful thinking. A good third-party study will include both, but it should clearly distinguish between them. If a report only shows owner satisfaction scores, ask whether the owners knew their pet was receiving the product.

We also look for consistency across measures. For instance, a joint supplement that improves owner-reported mobility but shows no change in objective gait analysis may have a placebo effect rather than a true physiological benefit.

Worked Example: Evaluating a Probiotic for Digestive Health

Let us walk through a realistic scenario. Imagine a brand of probiotic chews for dogs claims “clinically proven to reduce digestive upset.” They provide a link to a study on their website. Here is how we would evaluate it.

Step 1: Identify the Tester

First, we check who conducted the study. If the authors are all employees of the brand, or if the study was done at a lab that lists the brand as a client, it is proprietary. If the study is from a university veterinary school with a disclosure of funding but no editorial control by the brand, it is closer to third-party. In this example, the study is from a well-known veterinary college, and the authors state that the brand provided the product but had no role in study design, data analysis, or reporting. That is a good sign.

Step 2: Examine the Design

The study enrolled 40 dogs with mild chronic diarrhea, randomly assigned to either the probiotic or a placebo. The owners, the veterinarians assessing stool quality, and the statistician were all blinded. The study ran for 4 weeks. This design is solid, though the sample size is modest. The primary outcome was a standardized stool consistency score recorded daily by owners. Secondary outcomes included frequency of defecation and a quality-of-life questionnaire.

Step 3: Look at the Results

The probiotic group showed a statistically significant improvement in stool consistency compared to placebo, with a p-value of 0.03. However, the effect size was small: on a 5-point scale, the average improvement was 0.4 points. The quality-of-life scores did not differ between groups. The study also reported that 5 dogs in the probiotic group had mild gas, while 2 in the placebo group did.

Step 4: Interpret the Findings

This study suggests the probiotic may have a real but modest effect on stool consistency. The small effect size and lack of improvement in quality of life mean it is not a miracle cure. The adverse events (gas) were minor. For a dog with mild chronic diarrhea, this product might be worth trying, but we would not expect dramatic changes. The third-party design gives us more confidence than a proprietary study would, but we still need to consider the modest effect.

This example shows how a well-conducted third-party study can inform a nuanced decision—not just “it works” or “it doesn’t.”

Edge Cases and Exceptions

Not every product category fits neatly into the proprietary-vs-third-party framework. Some situations require special consideration.

Products with No Practical Blinding

For items like calming vests, pheromone diffusers, or textured mats, blinding is nearly impossible. The owner can see or smell the product. In these cases, third-party testing often relies on objective behavioral measures (e.g., video-recorded activity levels scored by a blinded observer) or physiological markers (e.g., cortisol levels). If a study on a calming product only uses owner surveys and does not blind the owner, the placebo effect could be large. We have seen products with strong owner satisfaction but no objective benefit. When evaluating such studies, prioritize objective outcomes.

Small Niche Products and Exotic Pets

For products aimed at small populations—like ferret supplements or reptile lighting—it may be impractical to run a large randomized trial. In these niches, a well-done proprietary study with careful design may be the best available evidence. The key is transparency: the brand should disclose the limitations openly. We are more forgiving of small sample sizes when the product category is inherently limited, but we still expect the study to be designed to minimize bias. A single-group before-and-after study with no control is not convincing, even for a rare species.

When “Third-Party” Is a Certification Label

Some products carry seals from organizations like the National Animal Supplement Council (NASC) or the Veterinary Oral Health Council (VOHC). These are not efficacy tests per se—NASC focuses on quality and manufacturing standards, while VOHC reviews existing data for dental products. These seals can be valuable signals of quality, but they do not replace a well-designed efficacy trial. A VOHC-accepted dental chew has met certain criteria for plaque and tartar reduction, but the underlying studies may still be proprietary. We recommend checking the specific data behind the seal.

Products That Claim “Vet-Formulated”

This phrase is common but meaningless without evidence. A product can be formulated by a veterinarian based on theoretical knowledge, but that does not prove it works in practice. We have seen “vet-formulated” supplements with no published data at all. Treat this as a marketing claim, not a substitute for testing.

Limits of the Approach

Even the best third-party testing has limitations. Understanding these will help you avoid over-reliance on any single study.

Individual Variation Between Animals

A study that shows a statistically significant effect at the group level does not guarantee the product will work for your specific pet. Some animals may be non-responders, and others may have adverse reactions. The average effect may be small, even if the study is well-designed. Always monitor your own pet’s response and discontinue use if you see no benefit or negative effects.

Publication Bias and the File Drawer Problem

Negative or null results are less likely to be published, whether in journals or on brand websites. This means the studies you see may be a biased sample. A brand that has run five studies may only show you the one that worked. Third-party testing reduces this risk if the study is pre-registered, but pre-registration is still rare in the pet supply world. When possible, look for a clinical trial registry entry (like the one at veterinarytrials.org) to see if a study was planned before results were known.

Cost and Accessibility Barriers

Third-party testing is expensive, and for small brands, the cost may be prohibitive. This does not mean their products are ineffective, but it does mean you have less evidence to go on. In such cases, we recommend relying on other signals: ingredient quality, manufacturing standards, and transparent communication about what the brand does and does not know. A brand that honestly says “we have not conducted a controlled trial yet” is more trustworthy than one that fakes a study.

The Limits of Any Single Study

No single study, no matter how well-designed, is definitive. Science advances through replication. If a product has only one third-party study, consider it promising but not proven. Look for multiple studies from different groups, ideally with consistent results. In the pet supply world, this level of evidence is rare, but it is becoming more common as the market matures.

Finally, remember that efficacy is not the only consideration. Safety, palatability, and cost also matter. A product with strong third-party evidence of efficacy may still be a poor choice if your pet refuses to eat it or if it causes side effects. Use third-party testing as one tool in your decision-making toolkit, not the only one.

We hope this guide helps you navigate the murky waters of pet supply claims. The next time you see “clinically proven,” you will know what questions to ask—and when to walk away.